Skip to main content

Fiscal Wizard · Single-issue tearsheet

CRVO / Jun 22, 2026 Run #7657

CRVO

CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Composite verdict

F 12.3 / 100
Bearish setup · Reversal 6 drivers · 4 gates blocking
  • Commodity Channel Index
  • MA Rejection
  • Money Flow Index
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 410th of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: volatile downtrend
Bull 0%Evidence: High · 13 signals100% Bear
Momentum Bearish 30Mean-reversion Bearish 25
  • Late-stage trendTrend signals have been live for 118 bars — past the ~60-bar window; momentum edge decays and can reverse late in a move. (medium confidence)
Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

21.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Earnings Yield 100
Free Cash Flow Yield 0
P/B 75
Revenue Growth (YoY) 0
P/E (TTM) 75
EPS Growth (YoY) 0

Technicals Bearish

3.2 / 100

Bearish setup leads (Commodity Channel Index, MA Rejection, Money Flow Index); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Commodity Channel Index 14
MA Rejection 15
Money Flow Index 20

Risk Gates

4 blocking 6 caution

4 guards active, 28 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for CRVO.